Press Releases

September 30, 2019 Lupin launches Sildenafil Tablets USP

September 25, 2019 Lupin Appoints Jon Stelzmiller as President of US SpecialtyBusiness

September 20, 2019 Lupin receives sANDA approval from U.S. FDA for Levothyroxine Sodium Tablets USP to be considered AB rated to Reference Listed Drug, UNITHROID®

September 13, 2019 Lupin Receives Health Canada Approval for Propranolol Hydrochloride ER Capsules

September 9, 2019 Lupin receives U.S. FDA approval for Ethacrynic Acid Tablets USP

September 6, 2019 Lupin receives U.S. FDA approval for Fosaprepitant for Injection

September 4, 2019 Lupin and Boehringer Ingelheim announce Partnership to Develop and Commercialize Novel Oncology Drug to treat KRAS-driven Cancers

August 26, 2019 Lupin’s subsidiary in South Africa announces Commercial Agreement with Creso Pharma for hemp oil based cannaQIX

August 22, 2019 Lupin divests Kyowa Criticare to Neopharma group